Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene

Japanese Journal of Cancer Research

Volumn 90, Issue 4, 1999, Pages 460-468

  Ohtake, Yuichiro ^a   Chen, Jiabing ^a   Gamou, Shinobu ^b   Takayanagi, Atsushi ^a   Mashima, Yukihiko ^a   Oguchi, Yoshihisa ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Anti EGF receptor antibody; Endocytosis; Gene therapy; Immunogene; Melanoma

Indexed keywords

BETA GALACTOSIDASE; CYTOSINE DEAMINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUCYTOSINE; GANCICLOVIR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; POLYLYSINE; RECEPTOR ANTIBODY; THYMIDINE KINASE;

ARTICLE; CANCER GROWTH; COMPLEX FORMATION; CONJUGATE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOGENETICS; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SUICIDE GENE;

EID: 0032962173     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00770.x     Document Type: Article

References (33)

1. Halpern, A. C. and Schuchter, L. M. Prognostic models in melanoma. Semin. Oncol., 24, S2-S7 (1997).
2. Leong, S. P. L. Immunotherapy of malignant melanoma. Surg. Clin. North Am., 76, 1355-1381 (1996).
3. Moller, P. and Schadendorf, D. Somatic gene therapy and its implications in melanoma treatment. Arch. Dermatol. Res., 289, 71-77 (1997).
4. Behzadian, M. A. and Shimizu, N. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor. Cell Struct. Funct., 10, 219-232 (1985).
5. Ozawa, S., Ueda, M., Ando, N., Abe, O., Minoshima, S. and Shimizu, N. Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor. Int. J. Cancer, 43, 152-157 (1989).
6. Hirota, N., Ueda, M., Ozawa, S., Abe, O. and Shimizu, N. Suppression of an epidermal growth factor receptor-hyper-producing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Res., 49, 7106-7109 (1989).
7. Chen, J., Gamou, S., Takayanagi, A., Ohtake, Y., Ohtsubo, M. and Shimizu, N. Receptor-mediated gene delivery using Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approach. Cancer Gene Ther., 5, 357-364 (1998).
8. Shimizu, N., Chen, J., Gamou, S. and Takayanagi, A. Immunogene approach toward cancer gene therapy using the epidermal growth factor receptor-mediated gene delivery. Cancer Gene Ther., 3, 113-120 (1996).
9. Shimizu, N., Chen, J., Takayanagi, J. and Gamou, S. Use of the growth factor receptor-mediated endocytosis for therapeutic gene delivery: immunogene approach. Cell. Pharmacol. AIDS Sci., 3, 263-267 (1996).
10. Marquardt, H. and Todaro, G. J. Human transforming growth factor: production by a melanoma cell line, purification and initial characterization. J. Biol. Chem., 257, 5220-5225 (1982).
11. Imanishi, K., Yamaguchi, K., Suzuki, M., Honda, S., Yanaihara, N. and Abe, K. Production of transforming growth factor-alpha in human tumour cell lines. Br. J. Cancer, 59, 761-765 (1989).
12. Nanney, L. B., Coffey, R. J., Jr. and Ellis, D. L. Expression and distribution of transforming growth factor-α within melanocytic lesions. J. Invest. Dermatol., 103, 707-714 (1994).
13. Real, F. X., Rettig, W. J., Chesa, P. G., Melamed, M. R., Old, L. J. and Mendelsohn, J. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res., 46, 4726-4731 (1986).
14. de Wit, P. E., Moretti, S., Koenders, P. G., Weterman, M. A., van Muijen, G. N., Gianotti, B. and Ruiter, D. J. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J. Invest. Dermatol., 99, 168-173 (1992).
15. Gutman, M., Singh, R. K., Radinsky, R. and Bareli, M. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res., 14, 1759-1766 (1994).
16. Koprowski, H., Herlyn, M., Balaban, G., Parmiter, A., Ross, A. and Nowell, P. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat. Cell Mol. Genet., 11, 297-302 (1985).
17. Kudlow, J. E., Khosravi, M. J., Kobrin, M. S. and Mak, W. W. Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells. J. Biol. Chem., 259, 11895-11900 (1984).
18. Worm, M., Makki, A., Dippel, E., Czarnetzki, B.M. and Schadendorf, D. Interferon-gamma downregulates epidermal growth factor receptors on human melanoma cells. Exp. Dermatol., 4, 30-35 (1995).
19. Hasumi, K., Sakamoto, G., Sugano, H., Kasuga, T. and Masubuchi, K. Primary malignant melanoma of the vagina: study of four autopsy cases with ultrastructural findings. Cancer, 42, 2675-2686 (1978).
20. Peebles, P. T., Trisch, T. and Papageorge, A. G. Isolation of four unusual pediatric solid tumor cell lines. Pediatr. Res., 12, 485 (1978).
21. Reid, T. W., Albert, D. M., Rabson, A. S., Russell, P., Craft, J., Chu, E. W., Tralka, T. S. and Wilcox, J. L. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst., 53, 347-360 (1974).
22. Fukuyama, R. and Shimizu, N. Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn. J. Cancer Res., 82, 8-11 (1991).
23. Gamou, S. and Shimizu, N. Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett., 357, 161-164 (1995).
24. Mullen, G. A., Kilstrup, M. and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89, 33-37 (1992).
25. Ohno, S., Akita, Y., Konno, Y., Imajoh, S. and Suzuki, K. A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell, 53, 731-741 (1988).
26. Bridgewater, J. A. and Gore, M. E. Biological response modifiers in melanoma. Br. Med. Bull., 51, 656-677 (1995).
27. Uchiyama, A., Hoon, D. S. B., Morisaki, T., Kaneda, Y., Yuzaki, D. H. and Morton, D. L. Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response. Cancer Res., 53, 949-952 (1993).
28. Nabel, G. J., Gordon, D., Bishop, D. K., Nickoloff, B. J., Yang, Z. Y., Aruga, A., Cameron, M. J., Nabel, E. G. and Chang, A. E. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc. Natl. Acad. Sci. USA, 93, 15388-15393 (1996).
29. Alijagic, S., Moller, P., Artuc, M., Jurgovsky, K., Czarnetzki, B. M. and Schadendorf, D. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol., 25, 3100-3107 (1995).
30. Vile, R. G. and Hart, I. R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res., 53, 3860-3864 (1993).
31. Bi, W. L., Parysek, L. M., Warnick, R. and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther., 4, 725-731 (1993).
32. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H. and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550-1552 (1992).
33. Rosenberg, S. A., Kawakami, Y., Robbins, P. F. and Wang, R. F. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv. Cancer Res., 70, 145-177 (1996).